Join
Live feed
·
INSIDERFilingvia Quantisnow
Angion Biomedica Corp. logo

SEC Form 4: Neylan John F. sold $1,545 worth of shares (374 units at $4.13) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 35,494 units (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
ANGN· Angion Biomedica Corp.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANGN (Angion Biomedica Corp.) and more on Quantisnow.